Cargando…

DOTA: Deep Learning Optimal Transport Approach to Advance Drug Repositioning for Alzheimer’s Disease

Alzheimer’s disease (AD) is the leading cause of age-related dementia, affecting over 5 million people in the United States and incurring a substantial global healthcare cost. Unfortunately, current treatments are only palliative and do not cure AD. There is an urgent need to develop novel anti-AD t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chyr, Jacqueline, Gong, Haoran, Zhou, Xiaobo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961573/ https://www.ncbi.nlm.nih.gov/pubmed/35204697 http://dx.doi.org/10.3390/biom12020196

Ejemplares similares

The assessment of efficient representation of drug features using deep learning for drug repositioning
por: Moridi, Mahroo, et al.
Publicado: (2019)

In silico drug repositioning using deep learning and comprehensive similarity measures
por: Yi, Hai-Cheng, et al.
Publicado: (2021)

Review of Drug Repositioning Approaches and Resources
por: Xue, Hanqing, et al.
Publicado: (2018)

Drug repositioning: a machine-learning approach through data integration
por: Napolitano, Francesco, et al.
Publicado: (2013)

Drug repositioning of herbal compounds via a machine-learning approach
por: Kim, Eunyoung, et al.
Publicado: (2019)

Machine learning and network medicine approaches for drug repositioning for COVID-19
por: Santos, Suzana de Siqueira, et al.
Publicado: (2021)

Repositioning Drugs to the Mitochondrial Fusion Protein 2 by Three-Tunnel Deep Neural Network for Alzheimer's Disease
por: Wang, Xun, et al.
Publicado: (2021)

Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
por: Corbett, Anne, et al.
Publicado: (2013)

β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease
por: Galeana-Ascencio, Roberto A., et al.
Publicado: (2023)

Systematic Approach for Drug Repositioning of Anti-Epileptic Drugs
por: Ko, Younhee, et al.
Publicado: (2019)

Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
por: Shim, Joong Sup, et al.
Publicado: (2014)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
por: Nishimura, Yuhei, et al.
Publicado: (2018)

Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining
por: Zhang, Ming, et al.
Publicado: (2016)

Robust Sampling of Defective Pathways in Alzheimer’s Disease. Implications in Drug Repositioning
por: Fernández-Martínez, Juan Luis, et al.
Publicado: (2020)

A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease
por: Lee, Soo Youn, et al.
Publicado: (2020)

Repositioning of drugs for Parkinson’s disease and pharmaceutical nanotechnology tools for their optimization
por: Hernández-Parra, Héctor, et al.
Publicado: (2022)

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients
por: Bayraktar, Abdulahad, et al.
Publicado: (2023)

Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach
por: Barbarossa, Alexia, et al.
Publicado: (2022)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Computational prognostic evaluation of Alzheimer’s drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches
por: Hassan, Mubashir, et al.
Publicado: (2023)

Learning Opportunities for Drug Repositioning via GWAS and PheWAS Findings
por: Yin, Wen, et al.
Publicado: (2018)

Systems pharmacology and drug repositioning- an integrated approach to metabolic diseases
por: Luther, Michael A
Publicado: (2012)

siRNA Genome Screening Approaches to Therapeutic Drug Repositioning
por: Perwitasari, Olivia, et al.
Publicado: (2013)

Drug-Repositioning Approaches Based on Medical and Life Science Databases
por: Zamami, Yoshito, et al.
Publicado: (2021)

System and network biology-based computational approaches for drug repositioning
por: Pandita, Vasundhara, et al.
Publicado: (2022)

A drug repositioning algorithm based on a deep autoencoder and adaptive fusion
por: Chen, Peng, et al.
Publicado: (2021)

Hybrid attentional memory network for computational drug repositioning
por: He, Jieyue, et al.
Publicado: (2020)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

GREP: genome for REPositioning drugs
por: Sakaue, Saori, et al.
Publicado: (2019)

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020)

Repositioning of Immunomodulators: A Ray of Hope for Alzheimer’s Disease?
por: Munafò, Antonio, et al.
Publicado: (2020)

Optimizing the Readout of Lanthanide-DOTA Complexes for the Detection of Ligand-Bound Copper(I)
por: Hanna, Jill R., et al.
Publicado: (2017)

Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach
por: Emig, Dorothea, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7begpggs154oda3o6igqrumh3q